Trial · NCT03127956
Results by group29
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 29
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Long-Term Safety Assessed Through Adverse Events and Local Skin Reactions | Olumacostat Glasaretil Gel, 5.0% | Adverse Events (Mild) | 197 | Participants | |
| Long-Term Safety Assessed Through Adverse Events and Local Skin Reactions | Olumacostat Glasaretil Gel, 5.0% | Adverse Events (Moderate) | 124 | Participants | |
| Long-Term Safety Assessed Through Adverse Events and Local Skin Reactions | Olumacostat Glasaretil Gel, 5.0% | Adverse Events (Severe) | 18 | Participants | |
| Long-Term Safety Assessed Through Adverse Events and Local Skin Reactions | Olumacostat Glasaretil Gel, 5.0% | Adverse Events (Not Reported) | 402 | Participants | |
| Long-Term Safety Assessed Through Adverse Events and Local Skin Reactions | Olumacostat Glasaretil Gel, 5.0% | Burning/Stinging (None) | 518 | Participants | |
| Long-Term Safety Assessed Through Adverse Events and Local Skin Reactions | Olumacostat Glasaretil Gel, 5.0% | Burning/Stinging (Mild) | 11 | Participants | |
| Long-Term Safety Assessed Through Adverse Events and Local Skin Reactions | Olumacostat Glasaretil Gel, 5.0% | Burning/Stinging (Moderate) | 2 | Participants | |
| Long-Term Safety Assessed Through Adverse Events and Local Skin Reactions | Olumacostat Glasaretil Gel, 5.0% | Burning/Stinging (Severe) | 0 | Participants | |
| Long-Term Safety Assessed Through Adverse Events and Local Skin Reactions | Olumacostat Glasaretil Gel, 5.0% | Burning/Stinging (Not Reported) | 210 | Participants | |
| Long-Term Safety Assessed Through Adverse Events and Local Skin Reactions | Olumacostat Glasaretil Gel, 5.0% | Pruritus (None) | 500 | Participants | |
| Long-Term Safety Assessed Through Adverse Events and Local Skin Reactions | Olumacostat Glasaretil Gel, 5.0% | Pruritus (Mild) | 29 | Participants | |
| Long-Term Safety Assessed Through Adverse Events and Local Skin Reactions | Olumacostat Glasaretil Gel, 5.0% | Pruritus (Moderate) | 2 | Participants | |
| Long-Term Safety Assessed Through Adverse Events and Local Skin Reactions | Olumacostat Glasaretil Gel, 5.0% | Pruritus (Severe) | 0 | Participants | |
| Long-Term Safety Assessed Through Adverse Events and Local Skin Reactions | Olumacostat Glasaretil Gel, 5.0% | Pruritus (Not Reported) | 210 | Participants | |
| Long-Term Safety Assessed Through Adverse Events and Local Skin Reactions | Olumacostat Glasaretil Gel, 5.0% | Erythema (None) | 469 | Participants | |
| Long-Term Safety Assessed Through Adverse Events and Local Skin Reactions | Olumacostat Glasaretil Gel, 5.0% | Erythema (Mild) | 55 | Participants | |
| Long-Term Safety Assessed Through Adverse Events and Local Skin Reactions | Olumacostat Glasaretil Gel, 5.0% | Erythema (Moderate) | 7 | Participants | |
| Long-Term Safety Assessed Through Adverse Events and Local Skin Reactions | Olumacostat Glasaretil Gel, 5.0% | Erythema (Severe) | 0 | Participants | |
| Long-Term Safety Assessed Through Adverse Events and Local Skin Reactions | Olumacostat Glasaretil Gel, 5.0% | Erythema (Not Reported) | 210 | Participants | |
| Long-Term Safety Assessed Through Adverse Events and Local Skin Reactions | Olumacostat Glasaretil Gel, 5.0% | Dryness (None) | 485 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03127956/results